Ned Sharpless, MD, Testifies Before House Subcommittee on FDA Investigation of Vaping Illnesses and Regulation of E-Cigarettes

Earlier this week, Acting Commissioner of the U.S. Food and Drug Administration (FDA) Ned Sharpless, MD, testified before the U.S. House Energy and Commerce Subcommittee on the FDA’s planned regulation of electronic nicotine delivery systems and investigation of vaping illnesses. His remarks are reproduced below.

https://www.ascopost.com/issues/october-10-2019/fda-acting-commissioner-testifies-before-house-subcommittee-on-fda-investigation-of-vaping-illnesses-and-regulation-of-e-cigarettes/